---
$id: https://graph.org.ai/products/commodity/51111874
$type: Product
source: UNSPSC
code: "51111874"
title: "Tamoxifen citrate"
class: "51111800"
classTitle: "Hormones and antihormones"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Tamoxifen citrate

**UNSPSC Code**: 51111874
**Class**: [Hormones and antihormones](Hormones and antihormones.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a selective estrogen receptor modulator and protein kinase c inhibitor with the molecular formula C26H29NO.C6H8O7, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7FRV7310N6. European Medicines Agency schedules tamoxifen citrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04672MIG. The term tamoxifen citrate is a United States Adopted Name designation. Most nations, for tariff and trade purposes, schedule tamoxifen citrate under HS 29221990 and SITC 51461. As of Q4 2014, TAMOXIFEN CITRATE remains US FDA's Preferred Term for this commodity. Tamoxifen citrate bears US NLM identifiers UMLS ID C0919390 and NCI Concept Code C855. SMILES: CC/C(=C(\C1CCCCC1)/C2CCC(CC2)OCCN(C)C)/C3CCCCC3.C(C(=O)O)C(CC(=O)O)(C(=O)O)O.

